Prognostic value of loss of heterozygosity at chromosome 9p in nonmuscle-invasive bladder cancer

Urology

Volumn 76, Issue 2, 2010, Pages 513.e13-513.e18

  Ploussard, Guillaume ^a   Dubosq, Francis ^a   Soliman, Hany ^a   Verine, Jérôme ^a   Desgrandchamps, François ^a   De Thé, Hugues ^a   Mongiat Artus, Pierre ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTERFERON;

ADULT; ARTICLE; BLADDER CANCER; CHROMOSOME 9P; HETEROZYGOSITY LOSS; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; TUMOR GROWTH; TUMOR RECURRENCE;

EID: 77955714872     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.03.037     Document Type: Article

References (27)

1. A. Stenzl, N.C. Cowan, M. De Santis, G. Jakse, M.A. Kuczyk, and A.S. Merseburger The updated EAU guidelines on muscle-invasive and metastatic bladdercancer Eur Urol 2009
2. R.J. Sylvester, A.P. van der Meijden, W. Oosterlinck, J.A. Witjes, C. Bouffioux, and L. Denis Predicting recurrence and progression in individual patients with stage ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 2006 466-465
3. M. Burger, S.J. Burger, S. Denzinger, P.J. Wild, W.F. Wieland, and H. Blaszyk Elevated microsatellite instability at selected tetranucleotide repeats does not correlate with clinicopathologic features of bladder cancer Eur Urol 50 2006 770 775
4. J.W. Catto, G. Xinarianos, J.L. Burton, M. Meuth, and F.C. Hamdy Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability Int J Cancer 105 2003 484 490
5. A.P. Berger, W. Parson, A. Stenzl, H. Steiner, G. Bartsch, and H. Klocker Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissue Eur Urol 41 2002 532 539
6. P. Cairns, M.E. Shaw, and M.A. Knowles Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9 Oncogene 8 1993 1083 1085
7. N. Miyao, Y.C. Tsai, S.P. Lerner, A.F. Olumi, C.H. Spruck 3rd, and M. Gonzalez-Zulueta Role of chromosome 9 in human bladder cancer Cancer Res 53 1993 4066 4070
8. I. Orlow, P. Lianes, L. Lacombe, G. Dalbagni, V.E. Reuter, and C. Cordon-Cardo Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors Cancer Res 54 1994 2848 2851
9. W.M. Stadler, J. Sherman, S.K. Bohlander, D. Roulston, M. Dreyling, and D. Rukstalis Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer Cancer Res 54 1994 2060 2063
10. P. Mhawech-Fauceglia, R.T. Cheney, and J. Schwaller Genetic alterations in urothelial bladder carcinoma: an updated review Cancer 106 2006 1205 1216
11. F. Kimura, A.R. Florl, H.H. Seifert, J. Louhelainen, S. Maas, and M.A. Knowles Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder Br J Cancer 85 2001 1887 1893
12. S. Hirao, T. Hirao, C.J. Marsit, Y. Hirao, A. Schned, and T. Devi-Ashok Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer Cancer 104 2005 1918 1923
13. D. Lindgren, F. Liedberg, A. Andersson, G. Chebil, S. Gudjonsson, and A. Borg Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q Oncogene 25 2006 2685 2696
14. R. Bartoletti, T. Cai, G. Nesi, L. Roberta Girardi, G. Baronti, and M. Dal Canto Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer J Surg Res 143 2007 422 427
15. B. Czerniak, V. Chaturvedi, L. Li, S. Hodges, D. Johnston, and J.Y. Roy Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer Oncogene 18 1999 1185 1196
16. P. Cairns, K. Tokino, Y. Eby, and D. Sidransky Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction Cancer Res 54 1994 1422 1424
17. J. Devlin, A.J. Keen, and M.A. Knowles Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2cM of IFNα Oncogene 9 1994 2757 2760
18. A.W. Hitchings, M. Kumar, S. Jordan, V. Nargund, J. Martin, and D.M. Berney Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb Br J Cancer 91 2004 552 557
19. M.G. Friedrich, C. Blind, K. Milde-Langosch, A. Erbersdobler, S. Conrad, and T. Loning Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence Eur Urol 40 2001 518 524
20. P. Korkolopoulou, P. Christodoulou, A. Lazaris, E. Thomas-Tsagli, P. Kapralos, and A. Papanikolaou Prognostic implications of aberrations in p16/pRb pathway in urothelial bladder carcinomas: a multivariate analysis including p53 expression and proliferation markers Eur Urol 39 2001 167 177
21. A.J. Keen, and M.A. Knowles Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder Oncogene 9 1994 2083 2088
22. M. Simoneau, T.O. Aboulkassim, H. LaRue, F. Rousseau, and Y. Fradet Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31 Oncogene 18 1999 157 163
23. T. Habuchi, O. Yoshida, and M.A. Knowles A novel candidate tumour suppressor locus at 9q32-33 in bladder cancer: localization of the candidate region within a single 840 kb YAC Hum Mol Genet 6 1997 913 919
24. N. Amira, S. Mourah, F. Rozet, P. Teillac, J. Fiet, and P. Aubin Noninvasive molecular detection of bladder cancer recurrence Int J Cancer 101 2002 293 297
25. T.S. Tzai, H.H. Chen, S.H. Chan, C.L. Ho, Y.S. Tsai, and H.L. Cheng Clinical significance of allelotype profiling for urothelial carcinoma Urology 62 2003 378 384
26. A. Erbersdobler, M.G. Friedrich, H. Schwaibold, R.P. Henke, and H. Huland Microsatellite alterations at chromosomes 9p, 13q, and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder Oncol Res 10 1998 415 420
27. S. Hernandez, E. Lopez-Knowles, J. Lloreta, M. Kogevinas, A. Amoros, and A. Tardon Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas J Clin Oncol 24 2006 3664 3671